Editöre Mektup
BibTex RIS Kaynak Göster

CRRT with Oxiris hemofilter as a new potential therapy in COVID-19: a case series

Yıl 2022, Cilt: 47 Sayı: 2, 908 - 909, 30.06.2022
https://doi.org/10.17826/cumj.1099705

Öz

CRRT with Oxiris hemofilter as a new potential therapy in COVID-19: a case series

Kaynakça

  • 1. Dawei Wang , Bo Hu , Chang Hu , Fangfang Zhu , Xing Liu , Jing Zhang et al., Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China, JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
  • 2. Qiurong Ruan , Kun Yang , Wenxia Wang , Lingyu Jiang , Jianxin Song ; Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
  • 3. Kwok Hong Chu , Wai Kay Tsang, Colin S Tang, Man Fai Lam, Fernand M Lai, Ka Fai To ; Acute renal impairment in coronavirus-associated severe acute respiratory syndrome, Kidney Int. 2005 Feb;67(2):698-705. doi: 10.1111/j.1523-1755.2005.67130.x.
  • 4. Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018;6:12. doi: 10.1186/s40635-018-0177-2.
  • 5. Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018 May;6(1):12. doi: 10.1186/s40635-018-0177-2.
  • 6. Broman ME, Bodelson M. Endotoxin And Cytokin Reduction Function Of The Oxiris Filter In A Prospective Double-Blinded Cross-Over Setting In Patients With Critical Gram-Septic Shock And Continuous Renal Replacement Therapy Requiring Acute Kidney Injury. Intensive Care Medicine Experimental. 2018;6(Suppl 2):0624. doi: 10.1371/journal.pone.0220444. eCollection 2019.
  • 7. Turani F, Busatti S, Martini S, Falco M, Gargano F, Barchetta R. Renal Replacement Therapy With The Oxiris Filter Decreases Inflammatory Mediators And Improves Cardiorenal Function In Septic Patients Better Then Cvhdf.A Cohort Study And A Propensity–Matched Analysis. Crit Care. 2018;22 Suppl 1:148. doi: 10.1159/000499589. Epub 2019 Apr 12.
  • 8. Marina Rieder, Daniel Duerschmied, Timm Zahn, Corinna Lang, Christoph Benk, Achim Lother et al., Cytokine Adsorption in Severe Acute Respiratory Failure Requiring Veno-Venous Extracorporeal Membrane Oxygenation, ASAIO J.2021 Mar 1;67(3):332-338. doi: 10.1097/MAT.0000000000001302.
  • 9. Klaus Kogelmann , Morten Scheller , Matthias Drüner , Dominik Jarczak , Use of hemoadsorption in sepsis-associated ECMO-dependent severe ARDS: A case series, J Intensive Care Soc. 2020 May;21(2):183-190. doi: 10.1177/1751143718818992. Epub 2019 Jan 8.
  • 10. Alexander Supady, Enya Weber, Marina Rieder, Achim Lother, Tim Niklaus, Timm Zahn et al., Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial, The Lancet, May 14, 2021 DOI:https://doi.org/10.1016/S2213-2600(21)00177-6.
  • 11. Maggo S, Dhull P, Dubey AP, Brashier D, Karan A, Singh NK, et al. Cytokine storm syndrome in COVID-19: Diagnosis and management strategies. Int J Health Sci Res. 2020;10:140–8.
  • 12. Monard C., Rimmelé T., Ronco C. (2019). Extracorporeal Blood Purification Therapies for Sepsis. Blood Purif. 2019;47 Suppl 3:1-14. doi: 10.1159/000499520. Epub 2019 Apr 11.
  • 13. Schwindenhammer V., Girardot T., Chaulier K., Grégoire A., Monard C., Huriaux L., et al. (2019). oXiris® Use in Septic Shock: Experience of Two French Centres. , Blood Purif. 2019;47 Suppl 3:1-7. doi: 10.1159/000499510. Epub 2019 Apr 12.
  • 14. Marcus E Broman , Fredrik Hansson , Jean-Louis Vincent , Mikael Bodelsson, Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study, PLoS One. 2019 Aug 1;14(8):e0220444. doi: 10.1371/journal.pone.0220444. eCollection 2019.
  • 15. Rieder M, Wengenmayer T, Staudacher D, Duerschmied D, Supady A. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation. Crit Care. 2020;24(1):435. doi: 10.1186/s13054-020-03130-y.
  • 16. Franco Turani , Riccardo Barchetta , Mauro Falco , Silvia Busatti , Luca Weltert, Continuous Renal Replacement Therapy with the Adsorbing Filter oXiris in Septic Patients: A Case Series, Blood Purif. 2019;47 Suppl 3:1-5. doi: 10.1159/000499589. Epub 2019 Apr 12.
  • 17. Turani F, Barchetta R, Falco M, Busatti S, Weltert L. Continuous renal replacement therapy with the adsorbing filter oXiris in septic patients: A case series. Blood Purif. 2019;47(Suppl 3):54–8. doi: 10.1159/000499589. Epub 2019 Apr 12.

Covid-19'da yeni potansiyel tedavi olarak Oxiris hemofiltreli CRRT: Bir vaka serisi

Yıl 2022, Cilt: 47 Sayı: 2, 908 - 909, 30.06.2022
https://doi.org/10.17826/cumj.1099705

Öz

COVID-19’da yeni potansiyel tedavi olarak Oxiris hemofiltreli CRRT: Bir vaka serisi

Kaynakça

  • 1. Dawei Wang , Bo Hu , Chang Hu , Fangfang Zhu , Xing Liu , Jing Zhang et al., Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China, JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
  • 2. Qiurong Ruan , Kun Yang , Wenxia Wang , Lingyu Jiang , Jianxin Song ; Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
  • 3. Kwok Hong Chu , Wai Kay Tsang, Colin S Tang, Man Fai Lam, Fernand M Lai, Ka Fai To ; Acute renal impairment in coronavirus-associated severe acute respiratory syndrome, Kidney Int. 2005 Feb;67(2):698-705. doi: 10.1111/j.1523-1755.2005.67130.x.
  • 4. Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018;6:12. doi: 10.1186/s40635-018-0177-2.
  • 5. Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018 May;6(1):12. doi: 10.1186/s40635-018-0177-2.
  • 6. Broman ME, Bodelson M. Endotoxin And Cytokin Reduction Function Of The Oxiris Filter In A Prospective Double-Blinded Cross-Over Setting In Patients With Critical Gram-Septic Shock And Continuous Renal Replacement Therapy Requiring Acute Kidney Injury. Intensive Care Medicine Experimental. 2018;6(Suppl 2):0624. doi: 10.1371/journal.pone.0220444. eCollection 2019.
  • 7. Turani F, Busatti S, Martini S, Falco M, Gargano F, Barchetta R. Renal Replacement Therapy With The Oxiris Filter Decreases Inflammatory Mediators And Improves Cardiorenal Function In Septic Patients Better Then Cvhdf.A Cohort Study And A Propensity–Matched Analysis. Crit Care. 2018;22 Suppl 1:148. doi: 10.1159/000499589. Epub 2019 Apr 12.
  • 8. Marina Rieder, Daniel Duerschmied, Timm Zahn, Corinna Lang, Christoph Benk, Achim Lother et al., Cytokine Adsorption in Severe Acute Respiratory Failure Requiring Veno-Venous Extracorporeal Membrane Oxygenation, ASAIO J.2021 Mar 1;67(3):332-338. doi: 10.1097/MAT.0000000000001302.
  • 9. Klaus Kogelmann , Morten Scheller , Matthias Drüner , Dominik Jarczak , Use of hemoadsorption in sepsis-associated ECMO-dependent severe ARDS: A case series, J Intensive Care Soc. 2020 May;21(2):183-190. doi: 10.1177/1751143718818992. Epub 2019 Jan 8.
  • 10. Alexander Supady, Enya Weber, Marina Rieder, Achim Lother, Tim Niklaus, Timm Zahn et al., Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial, The Lancet, May 14, 2021 DOI:https://doi.org/10.1016/S2213-2600(21)00177-6.
  • 11. Maggo S, Dhull P, Dubey AP, Brashier D, Karan A, Singh NK, et al. Cytokine storm syndrome in COVID-19: Diagnosis and management strategies. Int J Health Sci Res. 2020;10:140–8.
  • 12. Monard C., Rimmelé T., Ronco C. (2019). Extracorporeal Blood Purification Therapies for Sepsis. Blood Purif. 2019;47 Suppl 3:1-14. doi: 10.1159/000499520. Epub 2019 Apr 11.
  • 13. Schwindenhammer V., Girardot T., Chaulier K., Grégoire A., Monard C., Huriaux L., et al. (2019). oXiris® Use in Septic Shock: Experience of Two French Centres. , Blood Purif. 2019;47 Suppl 3:1-7. doi: 10.1159/000499510. Epub 2019 Apr 12.
  • 14. Marcus E Broman , Fredrik Hansson , Jean-Louis Vincent , Mikael Bodelsson, Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study, PLoS One. 2019 Aug 1;14(8):e0220444. doi: 10.1371/journal.pone.0220444. eCollection 2019.
  • 15. Rieder M, Wengenmayer T, Staudacher D, Duerschmied D, Supady A. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation. Crit Care. 2020;24(1):435. doi: 10.1186/s13054-020-03130-y.
  • 16. Franco Turani , Riccardo Barchetta , Mauro Falco , Silvia Busatti , Luca Weltert, Continuous Renal Replacement Therapy with the Adsorbing Filter oXiris in Septic Patients: A Case Series, Blood Purif. 2019;47 Suppl 3:1-5. doi: 10.1159/000499589. Epub 2019 Apr 12.
  • 17. Turani F, Barchetta R, Falco M, Busatti S, Weltert L. Continuous renal replacement therapy with the adsorbing filter oXiris in septic patients: A case series. Blood Purif. 2019;47(Suppl 3):54–8. doi: 10.1159/000499589. Epub 2019 Apr 12.
Toplam 17 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Klinik Tıp Bilimleri
Bölüm Editöre Mektup
Yazarlar

Feyza Özkan 0000-0003-0644-2670

Mohammed Deniz 0000-0002-2371-997X

Yayımlanma Tarihi 30 Haziran 2022
Kabul Tarihi 28 Nisan 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 47 Sayı: 2

Kaynak Göster

MLA Özkan, Feyza ve Mohammed Deniz. “Covid-19’da Yeni Potansiyel Tedavi Olarak Oxiris Hemofiltreli CRRT: Bir Vaka Serisi”. Cukurova Medical Journal, c. 47, sy. 2, 2022, ss. 908-9, doi:10.17826/cumj.1099705.